Novartis and Matchpoint Therapeutics have entered into a partnership worth $1bn to develop oral inhibitors for inflammatory ...

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by the European Commission (EC) to treat adults with ...

Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

We are thrilled to announce that Medscape Education has been honored with the SILVER Award in the Patient Education ...

Unlock the power of AI to transform pharma medical education, training, and critical insight gathering. Discover how next-gen ...

Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.

LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...

Abivax has shared positive top-line results from two late-stage studies of its investigational oral miR-124 enhancer in adults with moderately to severely active ulcerative colitis (UC).

Johnson & Johnson (J&J) has announced that its CD38-directed antibody Darzalex (daratumumab) has been approved by the ...

Rain Free Days® is a free migraine support app created by Teva, 11 London, and the migraine community. It helps users track ...

Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, ...

Roche’s oral PI3K inhibitor Itovebi (inavolisib) has been approved by the European Commission (EC) as part of a combination treatment for advanced breast cancer patients.